News Conference News EuroPCR 2025 Myval Noninferior to Other THVs at 1 Year, but Questions Persist L.A. McKeown May 21, 2025
News Conference News EuroPCR 2024 Myval Matches Contemporary TAVI at 30 Days, but Do More Sizes Matter? Shelley Wood May 15, 2024
News Conference News EuroPCR 2023 Up and Away: TAVI Early Discharge Protocols Safely Cut Length of Stay Michael O'Riordan May 18, 2023
News Conference News EuroPCR 2023 BASILICA, Chimney Stenting: No Clear Winner to Prevent TAVI Coronary Obstruction Michael O'Riordan May 16, 2023
News Conference News EuroPCR 2022 Next-Generation Navitor Valve Shows Promise in High-risk TAVI Patients Yael L. Maxwell May 27, 2022
News Conference News EuroPCR 2022 JenaValve Trilogy Meets the Challenge of AR in Early Real-World Use Caitlin E. Cox May 18, 2022
News Conference News EuroPCR 2017 TAVR Durability: Some Reassurances From CoreValve Trials Out to 9 Years Caitlin E. Cox May 17, 2017
News Conference News EuroPCR 2017 REPRISE III: Lotus Valve Matches CoreValve in First, Large Head-to-Head TAVR Trial Shelley Wood May 16, 2017
News Conference News EuroPCR 2012 TAVR Studies Tease Out Influences on Clinical Outcome Caitlin E. Cox May 18, 2012